These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 305736)

  • 1. An in-vitro model of malignant hyperthermia: differential effects of inhalation anesthetics on caffeine-induced muscle contractures.
    Reed SB; Strobel GE
    Anesthesiology; 1978 Apr; 48(4):254-9. PubMed ID: 305736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle.
    Britt BA; Endrenyi L; Frodis W; Scott E; Kalow W
    Can Anaesth Soc J; 1980 Jan; 27(1):12-5. PubMed ID: 7353185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.
    Strobel GE; Bianchi CP
    Anesthesiology; 1971 Nov; 35(5):465-73. PubMed ID: 5315431
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of volatile anesthetics on directly and indirectly stimulated skeletal muscle.
    Waud BE; Waud DR
    Anesthesiology; 1979 Feb; 50(2):103-10. PubMed ID: 35042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why does halothane relax cardiac muscle but contract malignant hyperthermic skeletal muscle?
    Ohnishi ST; Katsuoka M
    Adv Exp Med Biol; 1991; 301():73-87. PubMed ID: 1763705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford H; Imbenotte M
    Anesthesiology; 1992 Apr; 76(4):544-9. PubMed ID: 1372490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressant effects of volatile anesthetics upon rat and amphibian ventricular myocardium: insights into anesthetic mechanisms of action.
    Lynch C; Frazer MJ
    Anesthesiology; 1989 Mar; 70(3):511-22. PubMed ID: 2784293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temperature dependence of halothane-induced contractures of skeletal muscle.
    Suarez-Kurtz G; Sudo RT
    Muscle Nerve; 1986 Jan; 9(1):47-50. PubMed ID: 3951480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
    Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
    Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J
    Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.
    Nelson TE
    J Clin Invest; 1983 Sep; 72(3):862-70. PubMed ID: 6886007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
    Gallant EM; Godt RE; Gronert GA
    J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaesthetic-induced increase in ionised calcium in blood mononuclear cells from malignant hyperthermia patients.
    Klip A; Britt BA; Elliott ME; Pegg W; Frodis W; Scott E
    Lancet; 1987 Feb; 1(8531):463-6. PubMed ID: 2881037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia.
    Gronert GA
    Anesth Analg; 1979; 58(5):367-71. PubMed ID: 573559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.